This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Joseph, E.C. Articles by Kerns, W.D. Search for Related Content PubMed PubMed Citation Articles by Joseph, E.C. Articles by Kerns, W.D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                         What's this?

Characterization of Coronary Arterial Lesions in the Dog Following Administration of SK&F 95654, a Phosphodiesterase III Inhibitor

Toxicology Department, Sanofi Research Division, Willowburn Avenue, Alnwick, Northumberland NE66 2JH, United Kingdom

H.B. Jones

Safety of Medicines Department, Zeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom

W.D. Kerns

Department of Pathology and Toxicology, SmithKline Beecham, 709 Swedeland Road, King of Prussia, Pennsylvania 19479, USA

Drugs that inhibit the low-K_m, cGMP-inhibitable form of phosphodiesterase III (PDE III) are associated with arterial lesions in the extramural coronary arteries of dogs following oral and intravenous administration at high doses. Acute coronary arterial lesions have been investigated following administration to the dog of SK&F 95654, a potent PDE III inhibitor, and the progression of the lesion defined. Groups of 3 male beagle dogs received a single 2-hr infusion of SK&F 95654 at 8 mg/kg/hr and the characteristics of the coronary arterial lesions were evaluated at 1, 3, 10, and 34 days postdosing by light, scanning, and transmission electron microscopy. At 24 hr postdosing, the arterial lesion was characterized by segmental or circumferential necrosis of medial smooth muscle cells and hemorrhage; adventitial hemorrhage was also noted, particularly in the right atrial artery. Ultrastructural evaluation showed extensive medial necrosis, characterized by loss of smooth muscle cells and their replacement by cellular debris with ingress of erythrocytes, platelets, and inflammatory cells into the media. Associated with medial changes, significant endothelial effects were observed consisting of widening of intercellular boundaries, loss of normal elongated cellular appearance, and the attachment of numerous leukocytes and platelets. During the 10-34-day postdosing period, substantial repair of the arterial lesions occurred such that by day 34 all sections of extramural coronary artery were normal. The lesions induced in the dog are consistent with a hemodynamic effect induced by the pharmacological action of SK&F 95654.

Key Words: Vasodilator • medial necrosis • medial hemorrhage • arterial distension

Toxicologic Pathology, Vol. 24, No. 4, 429-435 (1996)
DOI: 10.1177/019262339602400405


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Louden, D. Brott, A. Katein, T. Kelly, S. Gould, H. Jones, G. Betton, J.-P. Valetin, and R. J. Richardson Biomarkers and Mechanisms of Drug-Induced Vascular Injury in Non-Rodents Toxicol Pathol, January 1, 2006; 34(1): 19 - 26. [Abstract] [Full Text] [PDF]

				G. N. Dietsch, C. R. Dipalma, R. J. Eyre, T. Q. Pham, K. M. Poole, N. B. Pefaur, W. D. Welch, E. Trueblood, W. D. Kerns, and S. T. Kanaly Characterization of the Inflammatory Response to a Highly Selective PDE4 Inhibitor in the Rat and the Identification of Biomarkers that Correlate with Toxicity Toxicol Pathol, January 1, 2006; 34(1): 39 - 51. [Abstract] [Full Text] [PDF]

				P. E. Losco, E. W. Evans, S. A. Barat, P. E. Blackshear, L. Reyderman, J. S. Fine, L. A. Bober, J. C. Anthes, E. J. Mirro, and F. M. Cuss The Toxicity of SCH 351591, a Novel Phosphodiesterase-4 Inhibitor, in Cynomolgus Monkeys Toxicol Pathol, April 1, 2004; 32(3): 295 - 308. [Abstract] [PDF]

				H. B. Jones, A. Macpherson, G. R. Betton, A. S. Davis, R. Siddall, and P. Greaves Endothelin Antagonist-Induced Coronary and Systemic Arteritis in the Beagle Dog Toxicol Pathol, April 1, 2003; 31(3): 263 - 272. [Abstract] [PDF]

				F. A.S. Clemo, W. E. Evering, P. W. Snyder, and M. A. Albassam Differentiating Spontaneous from Drug-Induced Vascular Injury in the Dog Toxicol Pathol, January 1, 2003; 31(1_suppl): 25 - 31. [Abstract] [PDF]

				Jun Zhang, E. H. Herman, A. Knapton, D. P. Chadwick, V. E. Whitehurst, J. E. Koerner, T. Papoian, V. J. Ferrans, and F. D. Sistare SK&F 95654-Induced Acute Cardiovascular Toxicity in Sprague-Dawley Rats--Histopathologic, Electron Microscopic, and Immunohistochemical Studies Toxicol Pathol, January 1, 2002; 30(1): 28 - 40. [Abstract] [PDF]

				M. A. Albassam, A. L. Metz, R. E. Potoczak, K. P. Gallagher, S. Haleen, H. Hallak, and E. J. Mcguire Studies on Coronary Arteriopathy in Dogs Following Administration of CI-1020, an Endothelin A Receptor Antagonist Toxicol Pathol, April 1, 2001; 29(3): 277 - 284. [Abstract] [PDF]

				M. A. Albassam, A. L. Metz, N. J. Gragtmans, L. M. King, G. E. Macallum, H. Hallak, and E. J. McGuire Coronary Arteriopathy in Monkeys Following Administration of CI-1020, an Endothelin A Receptor Antagonist Toxicol Pathol, March 1, 1999; 27(2): 156 - 164. [Abstract] [PDF]

				E.C. Joseph, J.A. Rees, and A.D. Dayan Mesenteric Arteriopathy in the Rat Induced by Phosphodiesterase III Inhibitors: An Investigation of Morphological, Ultrastructural, and Hemodynamic Changes Toxicol Pathol, July 1, 1996; 24(4): 436 - 450. [Abstract] [PDF]